| Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome |
|
Chakraborty, Rajshekhar
(Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai)
Mukkamalla, Shiva Kumar Reddy (Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai) Singam, Kranthi (Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai) Calderon, Natalia (Department of Internal Medicine, Queens Hospital Center, Icahn School of Medicine at Mount Sinai) |
| 1 | Toubai T, Tanaka J, Ota S, et al. Allogeneic bone marrow transplantation from an unrelated donor for the treatment of chronic myelogenous leukemia in blast crisis in a patient with Kleinfelter's syndrome. Leuk Lymphoma 2004;45:829-831. DOI ScienceOn |
| 2 | Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA; UK Clinical Cytogenetics Group. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 2005;97:1204-1210. DOI ScienceOn |
| 3 | Alimena G, Billstrom R, Casalone R, Gallo E, Mitelman F, Pasquali F. Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomalies. Cancer Genet Cytogenet 1985;16:207-218. DOI ScienceOn |
| 4 | Quintas-Cardama A, Kantarjian H, Talpaz M, et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood 2005;105:2281-2286. DOI ScienceOn |
| 5 | Huntly BJ, Guilhot F, Reid AG, et al. Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. Blood 2003;102:2205-2212. DOI ScienceOn |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
